[144] Teradyne, Inc. SEC Filing
Teradyne's Form 144 reports a proposed sale of 554 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $58,724 and an approximate sale date of 08/12/2025 on NASDAQ. The filing lists total shares outstanding as 159,073,532, indicating the position is very small relative to the company's capitalization. The securities were acquired by restricted stock vesting on 01/27/2025, and the consideration is recorded as compensation.
The notice also records a prior sale of the same 554 shares on 07/30/2025 for $58,574.42. The form includes the standard Rule 144 representation regarding absence of undisclosed material adverse information and a field for Rule 10b5-1 plan adoption if applicable, though no plan adoption date is provided in the filing.
Il Modulo 144 di Teradyne segnala una proposta di vendita di 554 azioni ordinarie tramite Fidelity Brokerage Services, con un valore di mercato complessivo di $58,724 e una data di vendita approssimativa del 12/08/2025 sul NASDAQ. Il deposito indica un totale di azioni in circolazione pari a 159,073,532, evidenziando che la posizione 猫 molto ridotta rispetto alla capitalizzazione della societ脿. I titoli sono stati acquisiti tramite vesting di azioni ristrette il 27/01/2025 e il corrispettivo 猫 registrato come compenso.
La comunicazione registra inoltre una vendita precedente delle medesime 554 azioni il 30/07/2025 per $58,574.42. Il modulo include la dichiarazione standard prevista dalla Regola 144 sull'assenza di informazioni materiali avverse non divulgate e un campo per l'eventuale adozione di un piano ai sensi della Rule 10b5-1, sebbene nel deposito non sia indicata alcuna data di adozione del piano.
El Formulario 144 de Teradyne informa sobre una propuesta de venta de 554 acciones ordinarias a trav茅s de Fidelity Brokerage Services, con un valor de mercado agregado de $58,724 y una fecha aproximada de venta del 12/08/2025 en NASDAQ. La presentaci贸n indica un total de acciones en circulaci贸n de 159,073,532, lo que se帽ala que la posici贸n es muy peque帽a en relaci贸n con la capitalizaci贸n de la compa帽铆a. Los valores fueron adquiridos por vesting de acciones restringidas el 27/01/2025 y la contraprestaci贸n se registra como 肠辞尘辫别苍蝉补肠颈贸苍.
El aviso tambi茅n registra una venta anterior de las mismas 554 acciones el 30/07/2025 por $58,574.42. El formulario incluye la representaci贸n est谩ndar de la Regla 144 sobre la ausencia de informaci贸n material adversa no divulgada y un campo para la adopci贸n de un plan Rule 10b5-1 si procede, aunque en la presentaci贸n no se indica fecha de adopci贸n del plan.
Teradyne鞚� Form 144電� Fidelity Brokerage Services毳� 韱淀暣 氤错喌欤� 554欤�鞚� 毵り皝 鞓堨爼 鞁犼碃毳� 旮半頃橁碃 鞛堨溂氅�, 齑� 鞁滌灔臧�旃� $58,724鞕� NASDAQ鞐愳劀鞚� 鞓堨儊 毵り皝鞚� 2025-08-12毳� 旮办灛頃橁碃 鞛堨姷雼堧嫟. 鞝滌稖靹滌棎電� 齑� 氚滍枆欤检嫕 靾橁皜 159,073,532欤�搿� 旮办灛霅橃柎 鞛堨柎 頃措嫻 氤挫湢臧� 須岇偓 鞁滉皜齑濎暋鞐� 牍勴暣 毵れ毎 鞛戩潃 攴滊鞛勳潉 雮橅儉雰呺媹雼�. 頃措嫻 歃濌秾鞚� 2025-01-27鞚� 鞝滍暅欤� 氩犾姢韺�(vesting)鞙茧 旆摑霅橃棃瓿�, 雽�臧�電� 氤挫儊(肠辞尘辫别苍蝉补迟颈辞苍)鞙茧 旮半霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 瓿奠鞐愲姅 霃欖澕頃� 554欤茧ゼ 2025-07-30鞐� $58,574.42鞐� 毵り皝頃� 鞚挫爠 瓯半灅霃� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞏戩嫕鞐愲姅 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒鞚� 攵�臁挫灛鞐� 甏�頃� Rule 144鞚� 響滌 歆勳垹瓿�, 頃措嫻霅橂姅 瓴届毎 Rule 10b5-1 頂岆灉 毂勴儩霝�鞚� 韽暔霅橃柎 鞛堨溂雮� 鞝滌稖靹滌棎電� 頂岆灉 毂勴儩鞚检澊 旮办灛霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Le formulaire 144 de Teradyne rapporte une cession propos茅e de 554 actions ordinaires via Fidelity Brokerage Services, d'une valeur de march茅 globale de 58 724 $ et d'une date approximative de vente le 12/08/2025 sur le NASDAQ. Le d茅p么t indique un total d'actions en circulation de 159,073,532, ce qui montre que la position est tr猫s faible par rapport 脿 la capitalisation de la soci茅t茅. Les titres ont 茅t茅 acquis par vesting d'actions restreintes le 27/01/2025 et la contrepartie est enregistr茅e comme 谤茅尘耻苍茅谤补迟颈辞苍.
L'avis enregistre 茅galement une vente ant茅rieure des m锚mes 554 actions le 30/07/2025 pour 58 574,42 $. Le formulaire comprend la d茅claration standard relative 脿 la Rule 144 concernant l'absence d'informations n茅gatives mat茅rialistes non divulgu茅es et un champ pour l'adoption 茅ventuelle d'un plan Rule 10b5-1, bien qu'aucune date d'adoption ne soit fournie dans le d茅p么t.
Das Form 144 von Teradyne meldet einen geplanten Verkauf von 554 Aktien Stammaktien 眉ber Fidelity Brokerage Services mit einem gesamten Marktwert von $58,724 und einem ungef盲hren Verkaufsdatum am 12.08.2025 an der NASDAQ. Die Einreichung gibt die insgesamt ausstehenden Aktien mit 159,073,532 an und zeigt damit, dass die Position im Verh盲ltnis zur Marktkapitalisierung des Unternehmens sehr gering ist. Die Wertpapiere wurden durch Vesting eingeschr盲nkter Aktien am 27.01.2025 erworben und der Gegenwert als 痴别谤驳眉迟耻苍驳 verbucht.
Die Mitteilung verzeichnet au脽erdem einen vorherigen Verkauf derselben 554 Aktien am 30.07.2025 蹿眉谤 $58,574.42. Das Formular enth盲lt die 眉bliche Rule-144-Erkl盲rung zur Abwesenheit nicht offengelegter, wesentlicher negativer Informationen sowie ein Feld zur Angabe einer m枚glichen Rule-10b5-1-Plan-Einf眉hrung, wobei im Einreichungsdokument kein Datum 蹿眉谤 die Plan-Einf眉hrung genannt wird.
- None.
- None.
Insights
TL;DR: Small, routine insider sale of vested shares; immaterial to capitalization and unlikely to move markets.
The filing documents a proposed sale of 554 shares versus 159.07 million shares outstanding, representing a negligible proportion of the float. The shares were acquired via restricted stock vesting on 01/27/2025 and listed for proposed sale on 08/12/2025, with a prior sale of the same quantity on 07/30/2025 for $58,574.42. From a market-impact perspective this is de minimis; from a disclosure perspective it complies with Rule 144 requirements and signals monetization of compensation rather than a material change in insider holdings.
TL;DR: Form 144 shows standard compliance; no governance red flags evident from provided details.
The document includes the required attestation about absence of undisclosed material adverse information and provides acquisition and payment details (restricted stock vesting; payment as compensation). No 10b5-1 plan adoption date is shown. Given the small size of the reported transactions and the clear characterization as vested compensation, the filing does not, on its face, raise governance concerns or indicate withholding of material information.
Il Modulo 144 di Teradyne segnala una proposta di vendita di 554 azioni ordinarie tramite Fidelity Brokerage Services, con un valore di mercato complessivo di $58,724 e una data di vendita approssimativa del 12/08/2025 sul NASDAQ. Il deposito indica un totale di azioni in circolazione pari a 159,073,532, evidenziando che la posizione 猫 molto ridotta rispetto alla capitalizzazione della societ脿. I titoli sono stati acquisiti tramite vesting di azioni ristrette il 27/01/2025 e il corrispettivo 猫 registrato come compenso.
La comunicazione registra inoltre una vendita precedente delle medesime 554 azioni il 30/07/2025 per $58,574.42. Il modulo include la dichiarazione standard prevista dalla Regola 144 sull'assenza di informazioni materiali avverse non divulgate e un campo per l'eventuale adozione di un piano ai sensi della Rule 10b5-1, sebbene nel deposito non sia indicata alcuna data di adozione del piano.
El Formulario 144 de Teradyne informa sobre una propuesta de venta de 554 acciones ordinarias a trav茅s de Fidelity Brokerage Services, con un valor de mercado agregado de $58,724 y una fecha aproximada de venta del 12/08/2025 en NASDAQ. La presentaci贸n indica un total de acciones en circulaci贸n de 159,073,532, lo que se帽ala que la posici贸n es muy peque帽a en relaci贸n con la capitalizaci贸n de la compa帽铆a. Los valores fueron adquiridos por vesting de acciones restringidas el 27/01/2025 y la contraprestaci贸n se registra como 肠辞尘辫别苍蝉补肠颈贸苍.
El aviso tambi茅n registra una venta anterior de las mismas 554 acciones el 30/07/2025 por $58,574.42. El formulario incluye la representaci贸n est谩ndar de la Regla 144 sobre la ausencia de informaci贸n material adversa no divulgada y un campo para la adopci贸n de un plan Rule 10b5-1 si procede, aunque en la presentaci贸n no se indica fecha de adopci贸n del plan.
Teradyne鞚� Form 144電� Fidelity Brokerage Services毳� 韱淀暣 氤错喌欤� 554欤�鞚� 毵り皝 鞓堨爼 鞁犼碃毳� 旮半頃橁碃 鞛堨溂氅�, 齑� 鞁滌灔臧�旃� $58,724鞕� NASDAQ鞐愳劀鞚� 鞓堨儊 毵り皝鞚� 2025-08-12毳� 旮办灛頃橁碃 鞛堨姷雼堧嫟. 鞝滌稖靹滌棎電� 齑� 氚滍枆欤检嫕 靾橁皜 159,073,532欤�搿� 旮办灛霅橃柎 鞛堨柎 頃措嫻 氤挫湢臧� 須岇偓 鞁滉皜齑濎暋鞐� 牍勴暣 毵れ毎 鞛戩潃 攴滊鞛勳潉 雮橅儉雰呺媹雼�. 頃措嫻 歃濌秾鞚� 2025-01-27鞚� 鞝滍暅欤� 氩犾姢韺�(vesting)鞙茧 旆摑霅橃棃瓿�, 雽�臧�電� 氤挫儊(肠辞尘辫别苍蝉补迟颈辞苍)鞙茧 旮半霅橃柎 鞛堨姷雼堧嫟.
頃措嫻 瓿奠鞐愲姅 霃欖澕頃� 554欤茧ゼ 2025-07-30鞐� $58,574.42鞐� 毵り皝頃� 鞚挫爠 瓯半灅霃� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 鞏戩嫕鞐愲姅 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒鞚� 攵�臁挫灛鞐� 甏�頃� Rule 144鞚� 響滌 歆勳垹瓿�, 頃措嫻霅橂姅 瓴届毎 Rule 10b5-1 頂岆灉 毂勴儩霝�鞚� 韽暔霅橃柎 鞛堨溂雮� 鞝滌稖靹滌棎電� 頂岆灉 毂勴儩鞚检澊 旮办灛霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Le formulaire 144 de Teradyne rapporte une cession propos茅e de 554 actions ordinaires via Fidelity Brokerage Services, d'une valeur de march茅 globale de 58 724 $ et d'une date approximative de vente le 12/08/2025 sur le NASDAQ. Le d茅p么t indique un total d'actions en circulation de 159,073,532, ce qui montre que la position est tr猫s faible par rapport 脿 la capitalisation de la soci茅t茅. Les titres ont 茅t茅 acquis par vesting d'actions restreintes le 27/01/2025 et la contrepartie est enregistr茅e comme 谤茅尘耻苍茅谤补迟颈辞苍.
L'avis enregistre 茅galement une vente ant茅rieure des m锚mes 554 actions le 30/07/2025 pour 58 574,42 $. Le formulaire comprend la d茅claration standard relative 脿 la Rule 144 concernant l'absence d'informations n茅gatives mat茅rialistes non divulgu茅es et un champ pour l'adoption 茅ventuelle d'un plan Rule 10b5-1, bien qu'aucune date d'adoption ne soit fournie dans le d茅p么t.
Das Form 144 von Teradyne meldet einen geplanten Verkauf von 554 Aktien Stammaktien 眉ber Fidelity Brokerage Services mit einem gesamten Marktwert von $58,724 und einem ungef盲hren Verkaufsdatum am 12.08.2025 an der NASDAQ. Die Einreichung gibt die insgesamt ausstehenden Aktien mit 159,073,532 an und zeigt damit, dass die Position im Verh盲ltnis zur Marktkapitalisierung des Unternehmens sehr gering ist. Die Wertpapiere wurden durch Vesting eingeschr盲nkter Aktien am 27.01.2025 erworben und der Gegenwert als 痴别谤驳眉迟耻苍驳 verbucht.
Die Mitteilung verzeichnet au脽erdem einen vorherigen Verkauf derselben 554 Aktien am 30.07.2025 蹿眉谤 $58,574.42. Das Formular enth盲lt die 眉bliche Rule-144-Erkl盲rung zur Abwesenheit nicht offengelegter, wesentlicher negativer Informationen sowie ein Feld zur Angabe einer m枚glichen Rule-10b5-1-Plan-Einf眉hrung, wobei im Einreichungsdokument kein Datum 蹿眉谤 die Plan-Einf眉hrung genannt wird.
FAQ
What does Teradyne (TER) report in this Form 144?
Who is the seller named in the filing for TER?
How were the shares being sold acquired?
Has the filer sold any TER shares in the past three months?
Which broker and exchange are listed for the proposed TER sale?
Does the Form 144 indicate a Rule 10b5-1 plan was used?
